SKYSTAR BIO-PHARMACEUTICAL CO
CIK 0001076939
Revenue (TTM)
—
Q3 Nov 2014
Net Income (TTM)
$12.43M
+69.5% YoY
Q3 Nov 2014
EPS Diluted (TTM)
$1.55
+65.1% YoY
Q3 Nov 2014
Gross Margin
—
Q3 Nov 2014
Operating Margin
—
Q3 Nov 2014
Net Margin
—
Q3 Nov 2014
Free Cash Flow (TTM)
—
Q3 Nov 2014
Cash
$14.63M
Q3 Nov 2014
Total Debt
$19.18M
Q3 Nov 2014
Shares Outstanding
8.7M sh
Q3 Nov 2014
Revenue & Net Income
EPS (Diluted)
Cash Flow
Revenue Growth (YoY)
No data available for this metric.